|
|
 |
|
Viewing report
|
|
|
|
U.S. Growth Factors Markets
Frost & Sullivan, Feb 2002
Medicinal Possibilities Hold Promise of Prosperous Market
Growth factor proteins are found naturally within the body and are essential
to the growth and repair of human tissue. Recent advances in genomic
technology have enabled scientists to identify the specific genes responsible
for their creation. This has allowed for the large-scale production of growth
factors, creating a market that holds tremendous promise.
This Frost & Sullivan analysis provides a comprehensive examination of the
U.S. growth factors markets. By identifying industry drivers and evaluating
emerging challenges, this study supplies your company with a resourceful
guide to market success.
Aging Population Fuels Need for More Effective, Less Invasive Therapies
One of the greatest challenges facing the healthcare providers who treat
America’s aging population is providing access to effective therapeutics that
stimulate repair in tissues and organ systems damaged by age and disease.
Currently, there are insufficient therapies that address the underlying loss of
tissue function inherent in degenerative disorders.
Alzheimer’s disease, malignancies, trauma, autoimmune disorders, and other
similar conditions create the need for more efficient and less invasive
therapies,” says the author. “It is expected that the increase in age-related
diseases will be the most crucial driver for the growth factors industry over
the next decade.
Development of New Delivery Methods Drive Industry Evolution
Growth factors resulted from the advent of human recombinant
technologies, where biotechnology successfully mimicked the necessary
regulatory proteins for the treatment of certain ailments. Thus, new
systems are also being developed for better delivery of growth factors.
As drug discovery continues to evolve, the number of proteins that will be
discovered, sequenced, and applied to treat human diseases will increase
exponentially,” states the analyst. “Innovative delivery systems will heighten
acceptance for the use of growth factors as viable and effective therapies well
into the future.”
This Frost & Sullivan study provides an in-depth analysis of the marketplace,
offering your company the inside information necessary to take advantage of
lucrative opportunities.
Additional Information
Market Participants
Amgen, Inc.
Aurogen, Inc.
Berlex Laboratories, Inc.
Biogen, Inc.
Biomira, Inc.
Boston Life Sciences, Inc.
CelMed
Chiron Corp.
Corvas International, Inc.
CuraGen Corp.
Curis, Inc.
Cytokine PharmaSciences, Inc.
Demegen, Inc.
Genentech, Inc.
Howmedica/Stryker Corp.
Human Genome Sciences, Inc.
Immunex Corp.
Interferon Sciences, Inc.
Johnson & Johnson/Ortho-McNeil
Ligand Pharmaceuticals, Inc.
Medtronic, Inc.
NeoTherapeutics, Inc.
Nobex Corp.
Receptron, Inc.
Regeneron Pharmaceuticals, Inc.
Regenesis
Roche Diagnostics Corp.
Schering-Plough Corp.
Scios, Inc.
Sigma-Aldrich Co.
Stryker Corp.
Sulzer Biologic, Inc.
SuperGen, Inc.
Theratechnologies
Wyeth Ayerst
ZymoGenetics, Inc.
Aerospace
Auto ID
Biotech
Chemicals
Conferencing
Consumer
e-Business
Environment
Food
Healthcare
Internet Security
IT
Latin America
Medical Devices
Motors
Pharmaceuticals
Power
Sensors
Smart Cards
Technical Insights
Telecom Services
Transportation
Water
Wireless
Customers who bought this item also bought
U.S. Blood Growth Factors Markets
Growth Factors (Blood And Tissue) - A World Report
Growth Factors (Blood And Tissue) - A World Report
Growth Factors ( Blood And Tissue ) - Global Strategic Business Report
Tissue Heart Valves: Aging Population in the US and Europe Bolstering Growth
Capitalizing on Opportunities in Cord Blood Industry Growth
Choices in Cord Blood Banking - Factors Influencing Parental Decision Making
U.S. Tissue Engineering Markets
Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth
U.S. Topical Hemostats and Tissue Sealants Markets
Transdermal Pain Management: Markets, Demand Factors, Forecasts, and Opportunities
Contract Manufacturing Strategies: Market Developments, Technology Transfer and Key Success Factors
|
|
|
|
